JAMES BAKER: Open Payments
NPI 1225086630 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 22 payments from 12 companies in 2025. Trend: 2023 $410 · 2024 $799 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $300 |
| Dexcom, Inc. | 4 | $98 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Exact Sciences Corporation | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $20 |
| Geron Corporation | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Verona Pharma, Inc. | 1 | $15 |
| Aveo Pharmaceuticals, Inc. | 1 | $15 |
Products named: Ozempic, Wegovy, Dexcom G6 Transmitter, BREZTRI, Cologuard Collection Kit, CARVYKTI, RYTELO, CONTRAVE.
Industry payments across AR — which companies pay providers there.
